Vanguard Group Inc Context Therapeutics Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,253,467 shares of CNTX stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,253,467

Previous 3,255,463 0.06%

Holding current value

$1.85 Million

Previous $3.22 Million 38.42%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$0.61 - $1.25 $1,217 - $2,495	-1,996 Reduced 0.06%	3,253,467 $1.98 Million
Q4 2024 Feb 11, 2025	SELL	$0.98 - $2.35 $479,708 - $1.15 Million	-489,498 Reduced 13.07%	3,255,463 $3.22 Million
Q3 2024 Nov 13, 2024	SELL	$1.79 - $2.66 $1.36 Million - $2.01 Million	-757,237 Reduced 16.82%	3,744,961 $7.34 Million
Q2 2024 Aug 13, 2024	BUY	$1.24 - $2.19 $4.84 Million - $8.55 Million	3,903,895 Added 652.49%	4,502,198 $9 Million
Q1 2024 May 10, 2024	BUY	$0.92 - $1.38 $2,107 - $3,161	2,291 Added 0.38%	598,303 $825,000
Q4 2023 Feb 14, 2024	BUY	$0.79 - $1.41 $1,991 - $3,554	2,521 Added 0.42%	596,012 $673,000
Q3 2023 Nov 14, 2023	BUY	$0.9 - $1.59 $16,911 - $29,877	18,791 Added 3.27%	593,491 $896,000
Q2 2023 Aug 14, 2023	BUY	$0.48 - $1.6 $624 - $2,080	1,300 Added 0.23%	574,700 $919,000
Q1 2023 May 15, 2023	SELL	$0.56 - $1.06 $37,779 - $71,510	-67,463 Reduced 10.53%	573,400 $321,000
Q4 2022 Feb 10, 2023	BUY	$0.61 - $1.42 $100 - $232	164 Added 0.03%	640,863 $416,000
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.08 $13,009 - $24,377	11,720 Added 1.86%	640,699 $711,000
Q2 2022 Aug 12, 2022	BUY	$1.29 - $2.66 $506,583 - $1.04 Million	392,700 Added 166.2%	628,979 $1.33 Million
Q1 2022 May 13, 2022	BUY	$1.72 - $2.82 $37,152 - $60,912	21,600 Added 10.06%	236,279 $513,000
Q4 2021 Feb 14, 2022	BUY	$2.66 - $7.45 $571,046 - $1.6 Million	214,679 New	214,679 $571,000

Others Institutions Holding CNTX

# of Institutions

Shares Held

79M

Call Options Held

Put Options Held

View Full List

About Context Therapeutics Inc.

Ticker CNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,966,100
Market Cap $9.1M
Description
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...

More about CNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Context Therapeutics Inc. Transaction History